Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian C Begg

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
International Journal of Radiation Oncology, Biology, Physics|July 2, 2005
Thymidine analogues to assess microperfusion in human tumorsHilde L Janssen, Anna S Ljungkvist, Paul F Rijken, et al.
International Journal of Radiation Oncology, Biology, Physics|April 19, 2006
Hypoxia in human colorectal adenocarcinoma: comparison between extrinsic and potential intrinsic hypoxia markersLaurence Goethals, Annelies Debucquoy, Christiaan Perneel, et al.
Gynecologic Oncology|November 27, 2007
Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancerGillian Thomas, Shamshad Ali, Frank J P Hoebers, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 24, 2004
Differentiation-associated staining with anti-pimonidazole antibodies in head and neck tumorsHilde L K Janssen, Frank J Hoebers, Debbie Sprong, et al.
International Journal of Radiation Oncology, Biology, Physics|May 26, 2005
Hypoxic cell turnover in different solid tumor linesAnna S E Ljungkvist, Johan Bussink, Johannes H A M Kaanders, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 30, 2010
HPV and high-risk gene expression profiles predict response to chemoradiotherapy in head and neck cancer, independent of clinical factorsMonique C de Jong, Jimmy Pramana, Joost L Knegjens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2015
Pretreatment microRNA Expression Impacting on Epithelial-to-Mesenchymal Transition Predicts Intrinsic Radiosensitivity in Head and Neck Cancer Cell Lines and PatientsMonique C de Jong, Jelle J Ten Hoeve, Reidar Grénman, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 23, 2002
Phase 1 study to identify tumour hypoxia in patients with head and neck cancer using technetium-99m BRU 59-21Frank J P Hoebers, Hilde L K Janssen, A Valdés Olmos, et al.
Head & Neck|July 7, 2007
Heterogeneity of gene expression profiles in head and neck cancerJimmy Pramana, Nuno Pimentel, Ingrid Hofland, et al.
International Journal of Radiation Oncology, Biology, Physics|September 9, 2009
A gene expression model of intrinsic tumor radiosensitivity: prediction of response and prognosis after chemoradiationSteven A Eschrich, Jimmy Pramana, Hongling Zhang, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
International Journal of Radiation Oncology, Biology, Physics|July 2, 2005
Thymidine analogues to assess microperfusion in human tumorsHilde L Janssen, Anna S Ljungkvist, Paul F Rijken, et al.
International Journal of Radiation Oncology, Biology, Physics|April 19, 2006
Hypoxia in human colorectal adenocarcinoma: comparison between extrinsic and potential intrinsic hypoxia markersLaurence Goethals, Annelies Debucquoy, Christiaan Perneel, et al.
Gynecologic Oncology|November 27, 2007
Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancerGillian Thomas, Shamshad Ali, Frank J P Hoebers, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 24, 2004
Differentiation-associated staining with anti-pimonidazole antibodies in head and neck tumorsHilde L K Janssen, Frank J Hoebers, Debbie Sprong, et al.
International Journal of Radiation Oncology, Biology, Physics|May 26, 2005
Hypoxic cell turnover in different solid tumor linesAnna S E Ljungkvist, Johan Bussink, Johannes H A M Kaanders, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 30, 2010
HPV and high-risk gene expression profiles predict response to chemoradiotherapy in head and neck cancer, independent of clinical factorsMonique C de Jong, Jimmy Pramana, Joost L Knegjens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2015
Pretreatment microRNA Expression Impacting on Epithelial-to-Mesenchymal Transition Predicts Intrinsic Radiosensitivity in Head and Neck Cancer Cell Lines and PatientsMonique C de Jong, Jelle J Ten Hoeve, Reidar Grénman, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 23, 2002
Phase 1 study to identify tumour hypoxia in patients with head and neck cancer using technetium-99m BRU 59-21Frank J P Hoebers, Hilde L K Janssen, A Valdés Olmos, et al.
Head & Neck|July 7, 2007
Heterogeneity of gene expression profiles in head and neck cancerJimmy Pramana, Nuno Pimentel, Ingrid Hofland, et al.
International Journal of Radiation Oncology, Biology, Physics|September 9, 2009
A gene expression model of intrinsic tumor radiosensitivity: prediction of response and prognosis after chemoradiationSteven A Eschrich, Jimmy Pramana, Hongling Zhang, et al.
Pageof 4